Expand ANVS Menu
ANVS MENU

ANVS Latest Press Releases

-- December 5, 2024 --

Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today's Marketplace Globe Newswire 8:30 AM

-- December 4, 2024 --

/C O R R E C T I O N -- Today's Marketplace/ PRNewswire 2:21 PM

-- November 25, 2024 --

Annovis to Host Year-End Investor Webcast on December 11, 2024 Globe Newswire 8:00 AM

-- November 12, 2024 --

Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB) Globe Newswire 8:00 AM

-- November 11, 2024 --

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- November 7, 2024 --

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist Globe Newswire 8:00 AM

-- October 31, 2024 --

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio Globe Newswire 8:00 AM

-- October 22, 2024 --

Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024 Globe Newswire 8:00 AM

-- October 15, 2024 --

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs Globe Newswire 8:00 AM

-- October 3, 2024 --

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases Globe Newswire 8:30 AM

-- October 2, 2024 --

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations Globe Newswire 8:30 AM

-- September 30, 2024 --

Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra Globe Newswire 8:00 AM

-- September 5, 2024 --

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 15, 2024 --

Annovis Bio Reports Second Quarter Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- August 6, 2024 --

Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities Globe Newswire 9:00 AM
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033 Globe Newswire 8:30 AM
Annovis' Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist Globe Newswire 8:00 AM

-- August 5, 2024 --

IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024 Globe Newswire 8:00 AM

-- July 24, 2024 --

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap Globe Newswire 8:00 AM

-- July 16, 2024 --

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap Globe Newswire 8:00 AM